[The neuromuscular blocking property of amikacin (author's transl)].
D000328:Adult; D000583:Amikacin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004357:Drug Synergism; D004491:Edrophonium / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D009466:Neuromuscular Blocking Agents; D011817:Rabbits; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D009466:Neuromuscular Blocking Agents; D007612:Kanamycin; D004491:Edrophonium; D000583:Amikacin; D013390:Succinylcholine; D002118:Calcium; D014403:Tubocurarine